Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2020

Nov 21, 2020

30071_dirs_2020-11-20_98977c6b-d085-4685-8d04-da99d824eff9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-19

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-19 ResMed Common Stock A 1187 Acquired 228636 Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 0 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 0 Indirect
ResMed Common Stock 22783 Indirect
ResMed Common Stock 21391 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 0 Indirect

Footnotes

F1: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date.

F2: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.

F3: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust dated December 2012.

F4: Larry Poster is the Trustee of the GRAT.

F5: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014.

F6: Funded as a gift from the Peter C. Farrell Family Trust on November 15, 2010, with a distribution date of November 15, 2011.